24 results
10-K
71d4z3f07w 3ivqb7
25 Mar 21
Annual report
8:01am
8-K
EX-10.1
yf6w9r77 yvc0bdgj3zx
2 Mar 21
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
9:00am
10-Q
jebfg6d
11 Aug 20
Quarterly report
4:05pm
424B4
yf41orhmg nk6qe
26 Jun 20
Prospectus supplement with pricing info
4:47pm
S-1/A
6xc3or sdf7bxk4daj
22 Jun 20
IPO registration (amended)
6:16am
S-1
EX-10.17
k5k9s
5 Jun 20
IPO registration
4:16pm
S-1
EX-10.15
jxcq7i0akvjm2s
5 Jun 20
IPO registration
4:16pm
S-1
mq9y2 kvw
5 Jun 20
IPO registration
4:16pm
DRS/A
EX-10.17
xvb1 wtbomz713nujc
19 May 20
Draft registration statement (amended)
12:00am